Utama › Sklerosis Pelbagai › Florida
Kajian klinikal Sklerosis Pelbagai di Florida
14 kajian untuk Sklerosis Pelbagai sedang mencari peserta di lokasi di Florida.
Bandar di Florida
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Aqualane Clinical Research, Naples
- USF Health, Tampa
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06782490A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Neurology Associates, PA, Maitland
Mengambil pesertaFasa 4
Umur 18 hingga 65 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07609719A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Altamonte Springs
- TG Therapeutics Investigational Trial Site, Boca Raton
- TG Therapeutics Investigational Trial Site, Clearwater
- dan 7 lagi
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06433752Clinical Applications of Advanced Ophthalmic Imaging
- Bascom Palmer Eye Institute, Miami
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 99 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT03135327RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of South Florida, Department of Psychiatry and Behavioral Neuroscience, Tampa
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Neurology of Central Florida- Site Number : 8400147, Altamonte Springs
- Aqualane Clinical Research- Site Number : 8400026, Naples
- Neurology Associates of Ormond Beach- Site Number : 8400086, Ormond Beach
- dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 60 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07325292Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- University of South Florida, Tampa
Mengambil pesertaFasa 3
Umur 10 hingga 17 · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06408259A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Neurology of Central FL Res Ctr, Altamonte Springs
- UF Health Cancer Center, Gainesville
- Homestead Assoc In Research Inc, Homestead
- dan 8 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT07225504Neurologic Stem Cell Treatment Study
- MD Stem Cells, Coral Springs
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Jun 2026 · NCT02795052Dry Needling in Multiple Sclerosis
- University of South Florida, Tampa
Mengambil peserta
Umur 18 hingga 80 · Semua jantina · Dikemas kini 29 Mei 2026 · NCT07615725Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
- Norman Fixel Institute for Neurological Diseases, Gainesville
- University of Florida, Gainesville
Mengambil peserta
Umur 18 hingga 100 · Semua jantina · Dikemas kini 6 Mac 2026 · NCT07376772Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis
- University of St. Augustine for Health Sciences, Saint Augustine
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 75 · Semua jantina · Dikemas kini 20 Mei 2025 · NCT06981013Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- Mayo Clinic Jacksonville, Jacksonville
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 18 hingga 80 · Semua jantina · Dikemas kini 2 Mei 2025 · NCT05395624Longitudinal Cognitive Assessment by BoCA
- Andrey Vyshedskiy, Miami
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 50 ke atas · Semua jantina · Dikemas kini 1 Ogo 2024 · NCT04114994Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.